Injection/Infusion
LIDOCAINE KABI SOLUTION FOR INJECTION 50MG/5ML
Summary
LIDOCAINE KABI SOLUTION FOR INJECTION 50MG/5ML — Injection/Infusion containing lignocaine hydrochloride. Hong Kong Registration No. HK-67903. Certificate Holder: FRESENIUS KABI HONG KONG LIMITED. Date of Registration: 18 Jul, 2023.
Product NameLIDOCAINE KABI SOLUTION FOR INJECTION 50MG/5ML
Registration No.HK-67903
Certificate HolderFRESENIUS KABI HONG KONG LIMITED
Holder AddressROOM 5001-16, 50/F, SUN HUNG KAI CENTRE, 30, HARBOUR ROAD, WAN CHAI, HONG KONG
Ingredientslignocaine hydrochloride
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration18 Jul, 2023
ATC codesC01BB01, C05AD01, D04AB01, N01BB02, R02AD02, S01HA07, S02DA01
ATC Classification
ATC level 1
C Cardiovascular System / D Dermatologicals / N Nervous System / R Respiratory System / S Sensory Organs
All ATC groupsC01, C05, D04, N01, R02, S01, S02
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。